THURSDAY, MAY 1, 2014 |
3:00 p.m.- 5:00 p.m.
|
VASA Board Meeting
|
6:00 p.m.- 7:30 p.m. Texas A
|
Welcome Reception
|
FRIDAY, MAY 2, 2014 |
7:00 a.m. - 8:00 a.m. Texas A | Continental Breakfast with Exhibitors
|
8:00 a.m. - 8:05 a.m. Texas C | Introduction from Program Directors
Theodore F. Saad, MD; John E. Aruny, MD; Lynda K. Ball, MSN, RN, CNN; David L. Cull, MD, FACS; Charmaine Lok, MD
|
8:05 a.m. - 8:15 a.m. Texas C | President’s Address Thomas M. Vesely, MD, President of VASA
|
8:15 a.m. - 8:25 a.m. Texas C | VASA 10th Anniversary A Frederick Schild, MD, VASA President 2004-2006
|
8:25 a.m. - 9:05 a.m. Texas C | Faculty Presentations: ARTERIOVENOUS FISTULAE
- Fistula “Balloon Maturation”: Facts & Fiction: Theodore F. Saad, MD
- Prevention of Needle-Site Aneurysms: Lynda K. Ball, MSN, RN, CNN
- Aneurysmorrhaphy: Surendra Shenoy, MD
|
9:05 a.m. - 9:45 a.m. Texas C | Faculty Presentations: STENTS
- Update on Stent-Graft Trials: RENOVA, REVISE, RESCUE: John Aruny, MD
- Stents for AV Fistulae: Past, Present, & Future: Timothy Clark, MD
- Stents or Stent-Grafts for Central Vein Disease: Dirk Hentschel, MD
|
9:45 a.m. - 10:15 a.m. Texas A | Morning Break
|
10:15 a.m. - 11:45 a.m. Texas C | Abstracts (#1-10)
1.01 Forearm Basilic Vein Transposition Provides Functional Autogenous Access after Failed Ipsilateral Proximal AV Access
Toufic Safa, MD, Surgery, St Francis Hospital, Great Neck, NY
1.02 First Week Postoperative Flow Measurements are Highly Predictive of Primary Patency of Radiocephalic Arteriovenous Fistulas
Eric Ladenheim, MD, Dzenan Lulic, MD, Craig Lum, MD, Nathan Chadwick, LDAC Vascular Centers, Fresno, CA
1.03 Description and Outcomes of a Simple Surgical Technique for Treating Arteriovenous Fistula Pseudoaneurysms
Angela L. Gucwa, MD, Christopher G. Carsten,III, MD, David L. Cull, MD, Greenville Health System, Greenville, SC
1.04 The Heterotopic Transplantation of the Shunt Vein - Maintenance of an Autologous Puncture Segment in Case of Irreversible Loss of the Ipsilateral Central Venous Drainage
Franziska Frizen, MD, vascular access surgery, DKD Wiesbaden, Wiesbaden, Germany
1.05 Prevention and Treatment of Aneurysms of Autogenous Dialysis Accesses
Stephen L. Hill, MD, Physicians Care of Virginia, Roanoke, VA
1.06 Covered Stents in the Management of Central Venous Stenosis
Marc G. Webb, MD
Michigan Vascular Access, Livonia, MI
1.07 In Vitro Study of AVF Outflow Vein Wall Shear Stress and Pulse Pressure
Howard M. Loree*, PhD, Nicholas Franano*, MD, George Agyapong*, Elyse G. Bailey*, Gwendolyn A. Ngai*, Geoff D. Tansley†, PhD *Flow Forward Medical, Inc., Lowell, MA; †School of Engineering, Griffith University, Gold Coast, QLD 4222, Australia
1.08 Long Segment Plication Technique for AV Fistulae Threatened By Diffuse Aneurysmal Degeneration: Short-term Results
Alexis Powell, MD, Dariam Cardentey-Oliva, Sean Cavanagh-Voss, Paul Armstrong, MD, Murray Shames, MD, Peter Nelson, MD, Aurelia Calero, MD, Charles J. Bailey, MD, Karl A. Illig, MD
University of South Florida, Tampa, FL
1.09 Outcomes of Arteriovenous Fistula Created Before Dialysis Start
Vesna Gerasimovska , PhD, Biljana Gerasimovska-Kitanovska, PhD, Aleksandar Sikole, PhD
Vascular access unit, Clinic of Nephrology, Skopje, Macedonia, The Former Yugoslav Republic of
1.10 ‘Fistula Fast’ - Initial Experience from a New, Rapid Access Arteriovenous Fistula Pathway
Damian McGrogan, Yazin Marie, Susan Freckleton, Helen Eddington, PhD, Clara Day, Nicholas Inston, PhD, Queen Elizabeth Hospital, Birmingham, United Kingdom
|
11:45 a.m. - 12:00 p.m. Texas C | Vascular Access in the UK Focus on Quality and Outcomes: Eric Chemla, MD
|
12:00 p.m. - 1:00 p.m. Texas A | Lunch
|
12:00 p.m. - 1:00 p.m. San Antonio 4-6 | Lunch Satellite Symposium
Presented by Gore and Associates
|
1:00 p.m. - 1:40 p.m. Texas C | Faculty Presentations: ARTERIOVENOUS GRAFTS
- Mythbuster Part-1: Are Grafts as “Bad” as We Think?: David Cull, MD
- Synthetic & Biological Grafts: What’s New?: Eric Peden, MD
- The Science of Vascular Access: New Frontiers: Nicholas Inston, MD, PhD
|
1:40 p.m. - 2:20 p.m. Texas C | Faculty Presentations: CARDIAC ISSUES IN AV ACCESS
- Radial Artery Cardiac Catheterization: Jeffrey Schussler, MD, FACC, FSCAI
- CHF & Pulmonary Hypertension Associated with AV Hemodialysis Access: Jan Malik, MD
- Cardiovascular Implantable Electronic Devices & Hemodialysis Access: Haimanot Wasse, MD
|
2:20 p.m. - 2:30 p.m. Texas C | Dialysis & Vascular Access in Colombia: Lessons for the USA Jaime Velez, MD
|
2:30 p.m. - 3:00 p.m. Texas A | Afternoon Break
|
3:00 p.m. - 4:30 p.m. Texas C | Abstracts (#11-20)
2.01 Initial Experience on Early Cannulation Using a New Tri-layer Graft for Vascular Access
Matteo Tozzi, MD, Gabriele Piffaretti, PhD, Marco Franchin, MD, Gabriele Soldini, MD, Mattia Cavagna, MD, Giulio Carcano, MD, Surgical and Morphological Sciences, University of Insubria, Varese, Italy
2.02 An Immediate Access Dialysis Graft that Prevents Traumatic Cannulation Related Injuries
Shawn M. Gage, PA, Roberto J. Manson, MD, Jeffrey H. Lawson, MD, PhD; Duke University Medical Center, Durham, NC
2.03 The Cost to Creation and Maintenance of Functional Arteriovenous Fistulas and Financial Losses in Capitated Models
Steven Abramowitz, MD, Robert A. Lookstein, MD, Harry Schanzer, MD, Peter L. Faries, MD, Michael M. Marin, MD, Victoria J. Teodorescu, MD,
Mount Sinai Medical Center, New York, NY
2.04 Optimal Hemodialysis Access from Start to Finish
Earl S. Schuman, MD, Amy Ronfeld, RN, Carolyn Beall, RN, Kaiser Northwest, Portland, OR
2.05 Evaluation and Treatment of High Flow Arteriovenous Fistulas after Successful Renal Transplantation
George Gkotsis*, MD, William Jennings, MD†, Alexandros Mallios*, MD, Kevin Taubman*, MD
*University of Oklahoma, Tulsa, OK; †St John Medical Center, Tulsa, OK
2.06 AV Fistula Salvage with Novel Patch-Wrap Technique
Jose Zamora II MD FACS, Balboa Transplant Institute, San Diego, CA
2.07 Use of the Artegraft in Salvage of Arteriovenous Fistulas for Dialysis
David B. Leeser*, MD, Silke Niederhaus*, MD, Patricia Rosenberry†, RN, Eugene Schweitzer*, MD
*University of Maryland Medical School, Baltimore, MD;
†Shore Regional Health System, Baltimore, MD
2.08 Ipsilateral Replacement Grafts - Using an Early Cannulation Graft to Avoid Catheter Exposure
Marc G. Webb, MD, Michigan Vascular Access, Livonia, MI
2.09 Cost Analysis of the Creation and Maintenance of Functional Arteriovenous Grafts for Hemodialysis
Neeraja Konuthula, Steven D. Abramowitz, MD, Harry Schanzer, MD, Peter L. Faries, MD, Michael M. Marin, Victoria J. Teodorescu, MD, Mount Sinai Medical Center, New York, NY
2.10 Avoiding the Use of a Femoral Bridging Hemodialysis Catheter in Selected Patients Using a Two-Stage HeRO Graft Implantation Technique
William J. Yoon, MD, David R. Lorelli, MD, Department of Surgery, Division of Vascular Surgery, St. John Hospital and Medical Center, Detroit, MI
|
4:30 p.m. - 5:00 p.m. Texas C | Video Presentations Suren Shenoy, MD
|
5:30 p.m. - 7:00 p.m. Texas A | VASA Networking Reception
|
SATURDAY, MAY 3, 2014 |
7:00 a.m. - 8:00 a.m. Texas A | Continental Breakfast with Exhibitors
|
7:00 a.m. - 8:00 a.m. San Antonio 4-6 | Satellite Symposium
Presented by CR Bard
|
8:00 a.m. - 8:05 a.m. Texas C
|
Introduction Program Committee Members
|
8:05 a.m. - 8:15 a.m. Texas C |
Nephrology Oral History Project Dugan Maddux, MD, FACP
|
8:15 a.m. - 8:45 a.m. Texas C | Faculty Presentations: PERITONEAL DIALYSIS
- Patient Selection is Key to Success: Ingemar Davidson, MD
- Methods of PD Catheter Insertion: Maurizio Gallieni, MD
|
8:45 a.m. - 9:25 a.m. Texas C | Faculty Presentations: VENOUS HEMODIALYSIS CATHETERS
- Mythbuster Part 2: Are Catheters as Bad as We Think?: Charmaine Lok, MD
- Catheter Designs, Materials, Coatings: What Really Matters?: Jack Work, MD
- Catheter Exit-Site: The Real Achilles Heel?: Deborah J. Brouwer-Maier, RN, CNN
|
9:25 a.m. - 9:45 a.m. Texas C |
ESRD Vascular Access Services in a Risk-Driven Payment System Robert Provenzano, MD
|
9:45 a.m. - 10:15 a.m. Texas A
|
Morning Break
|
10:15 a.m. - 11:45 a.m. Texas C |
Abstracts (#21-32)
3.01 Venous Outflow Stenosis: A Single Entity or Is the Cephalic Arch Different?
Andrew J. Jackson, MD, Emma L. Aitken, MD, Ram Kasthuri, MD, David B. Kingsmore, MD, Department of Transplantation, Glasgow, United Kingdom
3.02 Seasonal Variability of Fistula Thrombosis in a Temperate Climate
Andrew J. Jackson, MD, Emma L. Aitken, MD, David B. Kingsmore, MD, Department of Transplantation, Glasgow, United Kingdom
3.03 The Role of Exogenous Nitrates in Arteriovenous Fistula Maturation
John Yerxa*, Mostafa A. Gabr†, MD, Aamna Ali*, MD, Shawn M. Gage†, Roberto J. Manson†, MD, James C. Otto†, PhD, Jeffrey H. Lawson†, MD *Duke University School of Medicine, Durham, NC; †Duke University Department of Surgery, Durham, NC
3.04 Single-site Puncture Technique for Lateral Internal Jugular Vein Tunneled Hemodialysis Catheter Placement
Rodney S. Florek*, MD, Gabriel Rivera*, MD, Trac Le*, MD, M. Molina*, MD, Juan Gomez†, MD, Eva Wasilewska*, MD, Michael Helm*, MD
*West Jefferson Medical Center, Metairie, LA; †Tulane University Medical Center, New Orleans, LA
3.05 Outcomes of 500 Consecutive Arteriovenous Fistulas Performed by a Single Surgeon
John F. Lucas,III, MD, Rebecca McGlawn, RN, Greenwood Leflore Hospital, Greenwood, MS
3.06 Novel Approach to Percutaneous Thrombolysis in Large Caliber Clotted Vascular Access Using Ultrasound Accelerated Thrombolysis Technology
Jessica A. Zagory, MD, Paul E. Perkowski, MD, London Guidry, MD, Jon V. Schellack, MD, Louisiana State University Health Sciences Center New Orleans, New Orleans, LA
3.07 Utility and Safety of Pneumatic Tourniquet for Surgical Procedures of Hemodialysis Access Under Conscious Sedation
Shouwen Wang, MD, Surgery Center, Arizona Kidney Disease and Hypertension Center, Phoenix, AZ
3.08 A Randomised Controlled Trial Comparing Continuous to Interrupted Sutures for Radiocephalic Arteriovenous Fistulae
Emma Aitken, MD, Edward Jeans, MD, David Kingsmore, MD, Western Infirmary, Glasgow, United Kingdom
3.09 Outcomes of Combined Rheolytic and Rotational Mechanical Thrombectomy for Total Venous Circuit Thrombosis in Hemodialysis Patients
Nicholas J. Petruzzi*, MD, Raphael Cohen†, MD, Mark Mantell†, MD, Timothy W. Clark†, MD
*Interventional Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA; †Penn Presbyterian Medical Center, Philadelphia, PA
3.10 Overnight Low Dose Thrombolysis Increases Primary Patency Rate Of Upper Extremity Dialysis Grafts in Recanalization of Proximal Subclavian Vein Occlusion
Rodney S. Florek, MD, Radiology, Lourdes Regional Medical Center, Lafayette, LA; Juan Paredes MD, Vascular Surgery, Lourdes Regional Medical Center, Lafayette, LA; Gabriel Rivera MD, Nephrology, West Jefferson Medical Center, Marrero, LA; Trac Le MD, Nephrology, West Jefferson Medical Center, Marrero, LA; Miguel Molina MD, Nephrology, West Jefferson Regional Medical Center
|
10:15 a.m. - 12:00 p.m. San Antonio 1-3 |
Nurses & Techs Breakout Session Lynda K. Ball, MSN, RN, CNN
Patient Perspectives on Vascular Access
Dori Schatell, MS
Time: 20 minutes
Objectives:
- Define reframing and explain how it can be used to help patients cope with access-related body image concerns.
- Describe three strategies for helping dialysis patients to overcome needle fear.
Outline:
- Ambivalence about access
- Body image concerns
- How to help patients: reframing
- Coping with needle fear
- Blood-injection-needle phobia
- How to help patients: Strategies for overcoming needle fear
Fatal Vascular Access Hemorrhage
Lynda K. Ball, MSN, RN, CNN
Time: 45 minutes
Objectives:
- Evaluate an AV fistula for aneurysm formation and explain how aneurysms develop.
- Describe risk factors that can lead aneurysm formation and fatal hemorrhage.
- Describe how to control bleeding of a ruptured AV graft.
Outline:
- Assessment of the Venous Vascular System
- Stenosis
- High pressure
- Extended bleeding
- Aneurysm formation
- Vessel wall damage
- Cannulation issues
- Pseudoaneurysm formation
- Access wall damage
- Cannulation issues
- Non-healed skin over vascular access
- Infection
- Poor healing
- Patient issues
- Identified Risk Factors for Fatal Hemorrhage
- One-site-itis
- Stenosis
- Infection
- Erosion
- Hypertension
- Emergency Response for Access Rupture
- Direct pressure
- Elevation
- Call 911
Case Study on Access Hemorrhage
Bobby Inman, MSN, RN
Time: 20 minutes
Speaker Panel: Q & A on Vascular Access
Dori Schatell, Lynda Ball, Bobby Inman
Time: 20 minutes
|
11:45 a.m. - 11:55 a.m. Texas C |
Journal Club: Important Publications in Vascular Access 2012-2014 Thomas Vesely, MD
|
12:10 p.m. - 1:00 p.m. Texas A
|
Lunch
|
12:10 p.m. - 1:00 p.m. San Antonio 4-6
|
Business Lunch (Members Only)
|
1:00 p.m. - 1:05 p.m. Texas C
|
Introduction of Dr. Shenoy, Incoming VASA President
|
1:05 p.m. - 1:20 p.m. Texas C |
Henry Lecture: Bioengineered Grafts Jeffrey Lawson, MD
Introduction: Mitchell Henry, MD
|
1:20 p.m. - 2:50 p.m. Texas C |
Abstracts (#31-40)
4.01 The Exit Site Management Catheter - A Retrospective Evaluation of the First in Human Use of the NexSite HD Catheter
John Ross, MD, The Regional Medical Center, Orangeburg, SC
4.02 Severity of Swing-segment Stenosis Following Stage 1 Basilic Vein Transposition is not Predictive of Outcome in 2-Stage Basilic Vein Transposition
Mostafa A. Gabr, MD, John Yerxa, James C. Otto, PhD, Aamna Ali, MD, Shawn M. Gage, Jeffrey H. Lawson, MD, Duke University, Durham, NC
4.03 Suction Lipectomy of AVF and AVG Dramatically Reduces Central Venous Catheter Exposure
Gregg Miller*, MD, Walead Latif†, MD, Yevgeny Savransky††, MD, Elsie Koh, MD**, Dean Preddie*, MD, Aleksandr Khariton*, MD
*Fresenius Vascular Care of Brooklyn, Brooklyn, NY;
†Fresenius Vascular Care of Union, Union, NJ;
** Fresenius Vascular Care of Woodland Park, Woodland Park, NJ;
†† Fresenius Vascular Care of Bellmore, Bellmore, NY;
4.04 Surgical Treatment of Thrombosed Arteriovenous Fistulas and Grafts by Nephrologist
Andrey Yankovoy, Alexsandr Sinutin, Alexsandr Smoliacov, Victor Grankin, Vadim Stepanov
Moscow Regional Clinical Institut, Moscow, Russian Federation
4.05 Impact of Ambulatory Dialysis Access Center Approach to Conversion of Catheter Dependent Hemodialysis Patients to Arteriovenous Access
George Blessios, MD, Surgery, Catholic Health System, Buffalo, NY
4.06 Cutting Angioplasty Balloon in Native Av Fistulas - A Seven Year Experience
Aurangzaib Khawaja, Robert Jones, Nicholas Inston,Andrew Willis, Ian Maccafferty, Peter Riley, New Queen Elisabeth Hospital, Birmingham, United Kingdom
4.07 Retrograde Jugular Vein Access from the Inside-out: A Safer New Paradigm for Obtaining First Attempt Central Venous Access Even in High Risk Patients
Lakshmikumar Pillai*, MD, Thomas Lawson*, PhD, Patrick Burt*, Anatole Besarab†, MD, Mark H. Wholey**, MD
*Vascular Access Technologies, Inc., Palo Alto, CA;
†Henry Ford Hospital, Detroit, MI;
**Pittsburgh Vascular Institute, Pittsburgh, PA
4.08 Projecting Medical System Assets to Improve Access in Rural Areas
David B. Leeser*, MD, Patricia M. Rosenberry†, RN, Silke Niederhaus*, MD, Eugene Schweitzer, MD
*University of Maryland Medical School, Baltimore, MD;
†Shore Regional Health System, Baltimore, MD
4.09 Hemodialysis Associated Left Innominate Vein Compression Syndrome
Yaxue Shi, Jiejun Cheng, Wei Liang, Meng Ye, Yiping Zhao, Hao Zhang, Jiwei Zhang, Department of Vascular Surgery, Shanghai RenJi Hospital, Shanghai, China
4.10 "TV-Contrast Dump" For Central Vein Visualization During Peripheral Venograms
Da-Hee Park, Prakrati Kumar, MD, Dirk M. Hentschel, MD, Brigham and Women's Hospital, Boston, MA
|
2:50 p.m. - 3:10 p.m. Texas A |
Afternoon Break
|
3:10 p.m. - 4:10 p.m. Texas C |
Legal & Ethical Issues in Vascular Access
- Risk Reduction in Hemodialysis Access Surgery Practice
Lee L. Cameron, Jr, Esq
- Minimizing Risk and Liability of Venous Catheter Access
Maurizio Gallieni, MD
- End of Life Issues in Dialysis
Dorian Schatell, MS
Executive Director, Medical Education Institute, Madison, WI
- Legal Cases & Considerations in Vascular Access Larry Scher, MD
|
4:10 p.m. - 4:15 p.m. Texas C |
Conclude
|